• About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Abcuro.com

Breakthrough Therapies for Autoimmune Diseases & Cancer

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
  • Science
    • Overview
    • KLRG1
    • Abcuro Presentations & Publications
    • Other Publications
  • Programs
    • Overview
    • Ulviprubart
    • IBM
    • Clinical Trials
  • News
  • Careers
  • Contact

Selective Depletion of KLRG1+ T cells in a First-in-Human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM), GCOM 2022 Poster

June 6, 2022

Privacy Terms of Use

© 2026 Abcuro